ANALYSIS OF THE EFFICACY OF THE USE OF THERAPEUTIC AND PREVENTIVE MEDICINES IN PATIENTS WITH A LABORATORY-CONFIRMED DIAGNOSIS OF SARS-COV-2
Abstract and keywords
Abstract (English):
To date, there is a limited amount of literature that describes the use of oral therapeutic and prophylactic drugs in patients with a confirmed diagnosis of SARS-CoV-2. Therefore, this topic is relevant. Thus, the purpose of this study was to study the effectiveness of the use of therapeutic and prophylactic agents in patients with a laboratory-confirmed diagnosis of mild to moderate SARS-CoV-2, with or without concomitant oral co-infection. The data of the conducted study will constitute an important stage in the algorithm of specialized therapy. Materials and methods. A comparative analysis of the use of therapeutic and prophylactic agents for the oral cavity in patients with a confirmed diagnosis of SARS-CoV-2 was carried out. The conclusions are based on the results of a clinical study that compared the effectiveness of the use of therapeutic and prophylactic agents in 90 patients aged 20 to 87 years with mild to moderate Sars-CoV-2 with oral co-infection and 15 patients aged from 20 to 87 years of age with mild to moderate Sars-CoV-2 without coinfection. Results. During the study, the following results were obtained. The most effective drug was a solution of aqueous chlorhexidine 0.5%, but there was a side effect in the form of xerostomia. The Miramistin solution also had high efficiency, and the lowest efficiency was observed when using the Rotokan solution. Conclusions. The data of the conducted study will constitute an important stage in the algorithm of specialized therapy.

Keywords:
SARS-CoV-2, coronavirus, oral cavity, coinfection, plaque, aqueous chlorhexidine, miramistin, rotocan
References

1. Al' Kofish M., Usmanova I.N., Husnarizanova R.F., Kuznecova L.I., Gumerova M.I., Usmanov I.R., Sarvalieva A.F. Ocenka markerov razvitiya zabolevaniy parodonta na osnovanii izucheniya mikrobnogo sostava razlichnyh biotopov polosti rta. Problemy stomatologii. 2021;4:40-45. [M. Al Kofish, I.N. Usmanova, R.F. Khusnarizanova, L.I. Kuznetsova, M.I. Gumerova, I.R. Usmanov, A.F. Sarvalieva. Evaluation of markers for the development of periodontal diseases based on the study of the microbial composition of various biotopes of the oral cavity. Actual problems in dentistry. 2021;4:40-45. (In Russ.)]. https://doi.org/10.18481/2077-7566-20-16-4-40-45

2. Belocerkovskaya Yu.G., Romanovskih A.G., Smirnov I.P. COVID-19: Respiratornaya infekciya, vyzvannaya novym koronavirusom: novye dannye ob epidemiologii, klinicheskom techenii, vedenii pacientov. Consilium Medicum. 2020;3:12-20. [Yu.G. Belotserkovskaya, A.G. Romanovskikh, I.P. Smirnov. COVID-19: Novel Coronavirus Respiratory Infection: Update on Epidemiology, Clinical Course, and Case Management. Consilium Medicum. 2020;3:12-20. (In Russ.)]. https://elibrary.ru/item.asp?id=42745698

3. Vsemirnaya organizaciya zdravoohraneniya. Vspyshka koronavirusnoy infekcii COVID-19. [World Health Organization. Outbreak of coronavirus infection COVID-19. (In Russ.)]. https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019

4. Morozova S.V., Meytel' I.Yu. Kserostomiya: prichiny i metody korrekcii. Medicinskiy sovet. 2016;1:124-128. [S.V. Morozova, I.Yu. Meitel. Xerostomia: causes and methods of correction. Medical advice. 2016;1:124-128. (In Russ.)]. https://elibrary.ru/item.asp?id=27474988

5. Nikiforov V.V., Suranova T.G., Mironov A.Yu., Zabozlaev F.G. Novaya koronavirusnaya infekciya (COVID-19): etiologiya, epidemiologiya, klinika, diagnostika, lechenie i profilaktika. Moskva. 2020:48. [V.V. Nikiforov, T.G. Suranova, A.Yu. Mironov, F.G. Zabozlaev. New coronavirus infection (COVID-19): etiology, epidemiology, clinic, diagnosis, treatment and prevention. Moscow. 2020:48. (In Russ.)]. https://bashgmu.ru/upload/2_5233589981443786589.pdf

6. Al-Tawfiq J.A., Memish Z.A. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) // Expert review of anti-infective therapy. – 2017;3:269-275. doi: 10.1080/14787210.2017.1271712

7. Centers for Disease Control and Prevention. Coronavirus (COVID-19). https://www.cdc.gov/

8. Carvalho T. COVID-19 Research in Brief: December, 2019 to June, 2020 // Nat Med. – 2020;26:1152-1156. DOI: 10.1038/d41591-020-00026-w

9. European Centre for Disease Prevention and Control. COVID-19. https://www.ecdc.europa.eu/en

10. Junqiang L. et al. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia // Radiology. – 2020;1:18. doi: 10.1148/radiol.2020200236.

11. Huang S., Wang Wu, Li X., Ren L., Zhao J., Hu W. et al. Clinical features of patients infected with the new 2019 coronavirus in Wuhan // The Lancet. – 2020;15;395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5

12. Hui D.S.C., Zumla A. Review of severe acute respiratory syndrome: historical, epidemiological and clinical features // Infect Dis Clin North Am. – 2019;33(4):869-889. DOI: 10.1016/j.idc.2019.07.001

13. Greene J.G., Vermillion J.R. The Simplified Oral Hygiene Index // The Journal of the American Dental Association. – 1964;68(1):7-13. DOI: 10.14219/jada.archive.1964.0034

14. Koh H.W., Kim M.S., Lee J.S., Kim H., Park S.J. Changes in swine gut microbiota in response to swine epidemic diarrhea // Microbes Environ. – 2015;30(3):284-287. DOI: 10.1264/jsme2.ME15046

15. Khan A.A., Khan Z. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in the coronavirus outbreak // Bioinformatics. – 2020;1;36(13):4065-4069. DOI: 10.1093/bioinformatics/btaa28

16. Laura D. Kramer. Wadsworth Center, NYSDOH. https://foodandhealth.ru/bolezni/koronavirusy-covid-19/

17. Junqiang L. et al. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia // Radiology. – 2020;1:18. doi: 10.1148/radiol.2020200236.

18. Mammen M.J., Scannapieco F.A. Oral-lung microbiome interactions in lung diseases // Periodontol 2000. – 2020;83(1):234-241. DOI: 10.1111/prd.12301

19. Petersen P.E. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of the WHO Global Oral Health Programme // Community Dent Oral Epidemiol. – 2003;31:3-23. DOI: 10.1046/j..2003.com122.x

20. The Center for Systems Science and Engineering (CSSE) at Johns Hopkins. Coronavirus COVID-19 Global Cases. https://coronavirus.jhu.edu/map.html

21. «O pereprofilirovanii medicinskih organizaciy v gospital'nye bazy g. Ufy» (s izm. ot 13.04.2020g. № 318-A) [On the conversion of medical organizations into hospital bases in the city of Ufa (as amended on 13.04.2020g. No. 318-A) (In Russ.)]. https://bashgmu.ru

22. The New York Times. – Coronavirus Threatens Americans With Underlying Conditions. https://foodandhealth.ru/bolezni/koronavirusy-covid-19/

23. Le Figaro. – Coronavirus: alerte sur l’ibuprofène et autres anti-inflammatoires. https://www.lefigaro.fr/sciences/coronavirus-alerte-sur-l-ibuprofene-et-autres-anti-inflammatoires-20200314

24. Shour I., Massler M. Gingival disease in Postwar Italy(1945): prevalence of gingivitis in various coe groups // J AmDentAssoc. – 1947;35(2):475-482. DOI: 10.14219/jada.archive.1947.0266

25. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X. et al. A Novel Coronavirus from Patients with Pneumonia in China 2019. Novel Coronavirus Investigating and Research Team // N Engl J Med. – 2020;20;382(8):727-733. DOI: 10.1056/NEJMoa2001017

26. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet. – 2020;395(10229):1054-1062. DOI: 10.1016/S0140-6736(20)30566-3